Showing results (281-290 of 460) with videos related to

Sort By:
Pageof 46
AIDS (London, England)|August 11, 2007
Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapyTodd T Brown, Haitao Chu, Zhaojie Wang, et al.
Journal of Epidemiology and Community Health|August 15, 2006
Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoringXiuhong Li, Haitao Chu, Joel E Gallant, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 2010
Abasic sites preferentially form at regions undergoing DNA replicationPaul D Chastain, Jun Nakamura, Shangbang Rao, et al.
Epidemiology (Cambridge, Mass.)|April 14, 2010
The effect of HAART on HIV RNA trajectory among treatment-naïve men and women: a segmental Bernoulli/lognormal random effects model with left censoringHaitao Chu, Stephen J Gange, Xiuhong Li, et al.
Frontiers in Pharmacology|June 6, 2020
The Relationship Between Enlarged Perivascular Spaces and Cognitive Function: A Meta-Analysis of Observational StudiesWanxin Jie, Guanghong Lin, Zhou Liu, et al.
Journal of Tropical Pediatrics|April 5, 2023
Effect of integrated intervention to prevent child drowning in rural areas of Guangdong, China: a cluster randomized controlled trialRuilin Meng, Haofeng Xu, Mingqu Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|April 19, 2019
Incidence and mortality of primary bone cancers in China, 2014Liang Xia, Rongshou Zheng, Yanjun Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2006
Longitudinal anthropometric changes in HIV-infected and HIV-uninfected menTodd Brown, Zhaojie Wang, Haitao Chu, et al.
Chest|March 15, 2005
Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trialGerald W Staton, Willis H Williams, Elizabeth M Mahoney, et al.
Clinical Lung Cancer|September 5, 2024
Comparative Efficacy and Safety of Lorlatinib Versus Alectinib and Lorlatinib Versus Brigatinib for ALK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted Indirect ComparisonsChristine Garcia, Devin Abrahami, Anna Polli, et al.
Pageof 46